We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+1.09%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.6B
AUM Growth
+$69.6M
(+1.3%)
Cap. Flow
+$51.5M
Cap. Flow
% of AUM
0.92%
Top 10 Holdings %
Top 10 Hldgs %
21.06%
Holding
781
New
66
Increased
297
Reduced
239
Closed
62
Avg Time Held
1.3
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TD Ameritrade Holding Corp
AMTD
|
+$41.7M |
| 2 |
LyondellBasell Industries
LYB
|
+$33.9M |
| 3 |
Brookfield
BN
|
+$27.6M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$21.4M |
| 5 |
Becton Dickinson
BDX
|
+$20.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Polaris
PII
|
+$36M |
| 2 |
T. Rowe Price
TROW
|
+$31.5M |
| 3 |
Elevance Health
ELV
|
+$27.8M |
| 4 |
ITC
ITC HOLDINGS CORP
ITC
|
+$26.5M |
| 5 |
Applied Materials
AMAT
|
+$24.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.08% |
| 2 | Financials | 18.2% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Technology | 11.08% |
| 5 | Industrials | 10.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NPSN
376
DELISTED
NASPERS LTD
NPSN
| $518K | 0.01% |
3,327
-218
| -6% | -$33.9K |
2014 Q4
2 quarters
|
|
377
Intuitive Surgical
ISRG
$151B
| $515K | 0.01% |
9,567
-855
| -8% | -$47.8K |
2013 Q2
8 quarters
|
|
378
Fiserv Inc
FISV
$25.1B
| $514K | 0.01% |
12,420
-1,500
| -11% | -$60.3K |
2013 Q2
8 quarters
|
|
379
Silicon Motion
SIMO
$7.41B
| $510K | 0.01% |
14,750
-405
| -3% | -$13.2K |
2015 Q1
1 quarter
|
|
|
RKUS
380
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
| $509K | 0.01% |
49,207
| – | – |
2014 Q2
4 quarters
|
|
|
KRFT
381
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $505K | 0.01% |
5,929
+902
| +18% | +$77.6K |
2013 Q2
8 quarters
|
|
382
Vanguard S&P 500 ETF
VOO
$1.05T
| $501K | 0.01% |
2,655
+155
| +6% | +$29.9K |
2014 Q1
5 quarters
|
|
383
DELISTED
Accelerate Diagnostics
AXDX
| $500K | 0.01% |
1,938
| – | – |
2013 Q4
6 quarters
|
|
384
iShares Russell Mid-Cap ETF
IWR
$56.6B
| $494K | 0.01% |
11,604
+84
| +0.7% | +$3.65K |
2014 Q1
5 quarters
|
|
|
GGP
385
DELISTED
GGP Inc.
GGP
| $488K | 0.01% |
19,000
| – | – |
2013 Q2
8 quarters
|
|
386
iShares China Large-Cap ETF
FXI
$3.94B
| $480K | 0.01% |
10,415
+1,490
| +17% | +$73.8K |
2014 Q4
2 quarters
|
|
|
DATA
387
DELISTED
Tableau Software, Inc.
DATA
| $477K | 0.01% |
+4,138
| New | +$447K |
2015 Q2
0 quarters
|
|
388
Air Products & Chemicals
APD
$66B
| $474K | 0.01% |
3,746
| – | – |
2014 Q1
5 quarters
|
|
389
Waste Management
WM
$89.6B
| $471K | 0.01% |
10,154
-695
| -6% | -$34.9K |
2013 Q2
8 quarters
|
|
|
XENT
390
DELISTED
Intersect ENT, Inc
XENT
| $464K | 0.01% |
+16,224
| New | +$425K |
2015 Q2
0 quarters
|
|
391
Raymond James Financial
RJF
$30.3B
| $462K | 0.01% |
11,643
-1,767
| -13% | -$68.7K |
2014 Q1
5 quarters
|
|
392
ResMed
RMD
$34.1B
| $454K | 0.01% |
8,050
| – | – |
2013 Q2
8 quarters
|
|
393
Sasol
SSL
$10.2B
| $450K | 0.01% |
12,146
-547
| -4% | -$20.2K |
2014 Q2
4 quarters
|
|
394
Canadian Solar
CSIQ
$718M
| $449K | 0.01% |
15,700
+20
| +0.1% | +$686 |
2014 Q1
5 quarters
|
|
395
PEDEVCO
PED
$179M
| $449K | 0.01% |
4,994
+1,274
| +34% | +$142K |
2013 Q3
7 quarters
|
|
396
Howard Hughes
HHH
$4.17B
| $447K | 0.01% |
3,267
| – | – |
2013 Q2
8 quarters
|
|
|
ETP
397
DELISTED
Energy Transfer Partners L.p.
ETP
| $445K | 0.01% |
8,526
+423
| +5% | +$23.6K |
2013 Q2
8 quarters
|
|
398
Compass Minerals
CMP
$948M
| $442K | 0.01% |
5,381
+156
| +3% | +$13.7K |
2014 Q4
2 quarters
|
|
399
iShares MSCI Malaysia ETF
EWM
$259M
| $440K | 0.01% |
9,090
| – | – |
2013 Q2
8 quarters
|
|
|
PVTB
400
DELISTED
PrivateBancorp Inc
PVTB
| $436K | 0.01% |
10,956
| – | – |
2013 Q2
8 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, Geneva Advisors held 781 positions worth $5.6B, up 1.3% from $5.53B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geneva Advisors's Q2 2015 filing shows 66 new, 297 increased, 239 reduced and 62 closed positions. Its largest new stake was LinkedIn Corporation: 75,249 shares worth $15.5M. The largest sale was Polaris, an estimated $36M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geneva Advisors's largest Q2 2015 buy was LinkedIn Corporation: 75,249 shares worth $15.5M.
- Geneva Advisors added most to TD Ameritrade Holding Corp in Q2 2015, an estimated $41.7M increase.
- Geneva Advisors's biggest Q2 2015 reduction was Polaris, cutting an estimated $36M.
- Geneva Advisors fully exited Applied Materials in Q2 2015, selling an estimated $24.6M.
- Geneva Advisors's ten largest holdings make up 21% of its $5.6B portfolio in Q2 2015.
- Geneva Advisors opened 66 new positions and closed 62 in Q2 2015.
- Geneva Advisors's portfolio value rose 1.3% quarter-over-quarter to $5.6B.
Based on Geneva Advisors's 13F filing for Q2 2015, filed 3 Aug 2015.